Skip to main content
Jones Nauseef, MD, Oncology, New York, NY

Jones Trevor Nauseef MD PhD

Hematologic Oncology


Assistant Professor

Request Appointment
  • 505 E 70th StNew York, NY 10021

  • Book by Phone+1(229) 702-0319

  • Fax+1 212-746-4610

Overview of  Dr. Nauseef

Dr. Jones Nauseef is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 7 years. He is one of 369 doctors at New York-Presbyterian Hospital and one of 369 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 20 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2015

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate Cancer
    Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate CancerApril 18th, 2023
  • ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate Cancer
    ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate CancerFebruary 12th, 2021
  • ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate Cancer
    ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate CancerFebruary 11th, 2021
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: